Filing Details

Accession Number:
0001209191-18-059222
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-19 16:54:19
Reporting Period:
2018-11-16
Accepted Time:
2018-11-19 16:54:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1337553 Aerie Pharmaceuticals Inc AERI Biological Products, (No Disgnostic Substances) (2836) 203109565
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1589991 D. Gerald Cagle C/O Aerie Pharmaceuticals, Inc.
4301 Emperor Blvd., Suite 400
Durham NC 27703
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-16 2,000 $41.75 19,800 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41.72 to $41.749, inclusive.